FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943371536> ?p ?o ?g. }

• W2943371536 endingPage "391" @default.
• W2943371536 startingPage "377" @default.
• W2943371536 abstract "Objectives Reliable and timely HIV care cost estimates are important for policy option appraisals of HIV treatment and prevention strategies. As HIV clinical management and outcomes have changed, we aimed to update profiles of antiretroviral (ARV) usage pattern, patent/market exclusivity details and management costs in adults (≥ 18 years old) accessing HIV specialist care in England. Methods The data reported quarterly to the HIV and AIDS Reporting System in England was used to identify ARV usage pattern, and were combined with British National Formulary ( BNF ) prices, non‐ ARV care costs and patent/market exclusivity information to generate average survival‐adjusted lifetime care costs. The cumulative budget impact from 2018 to the year in which all current ARV s were expected to lose market exclusivity was calculated for a hypothetical 85 000 (± 5000) person cohort, which provided an illustration of potential financial savings afforded by bioequivalent generic switches. Price scenarios explored BNF 70 (September 2015) prices and generics at 10/20/30/50% of proprietary prices. The analyses took National Health Service ( NHS ) England's perspective (as the payer), and results are presented in 2016/2017 British pounds. Results By 2033, most currently available ARV s would lose market exclusivity; that is, generics could be available. Average per person lifetime HIV cost was ~£200 000 (3.5% annual discount) or ~£400 000 (undiscounted), reducing to ~£70 000 (3.5% annual discount; ~£120 000 undiscounted) with the use of generics (assuming that generics cost 10% of proprietary prices). The cumulative budget to cover 85 000 (± 5000) persons for 16 years (2018–2033) was £10.5 (± 0.6) billion, reducing to £3.6 (± 0.2) billion with the use of generics. Conclusions HIV management costs are high but financial efficiency could be improved by optimizing generic use for treatment and prevention to mitigate the high cost of lifelong HIV treatment. Earlier implementation of generics as they become available offers the potential to maximize the scale of the financial savings." @default.
• W2943371536 created "2019-05-09" @default.
• W2943371536 creator A5000850537 @default.
• W2943371536 creator A5004263068 @default.
• W2943371536 creator A5016565734 @default.
• W2943371536 creator A5020247445 @default.
• W2943371536 creator A5023567302 @default.
• W2943371536 creator A5030951835 @default.
• W2943371536 creator A5033851269 @default.
• W2943371536 creator A5039854648 @default.
• W2943371536 creator A5048657899 @default.
• W2943371536 creator A5058390204 @default.
• W2943371536 creator A5087209063 @default.
• W2943371536 creator A5087367098 @default.
• W2943371536 date "2019-04-29" @default.
• W2943371536 modified "2023-10-01" @default.
• W2943371536 title "<scp>HIV</scp> care cost in England: a cross‐sectional analysis of antiretroviral treatment and the impact of generic introduction" @default.
• W2943371536 cites W2018624849 @default.
• W2943371536 cites W2020037278 @default.
• W2943371536 cites W2106854762 @default.
• W2943371536 cites W2562813092 @default.
• W2943371536 cites W2611773854 @default.
• W2943371536 cites W2614048460 @default.
• W2943371536 cites W2782249864 @default.
• W2943371536 doi "https://doi.org/10.1111/hiv.12725" @default.
• W2943371536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31034159" @default.
• W2943371536 hasPublicationYear "2019" @default.
• W2943371536 type Work @default.
• W2943371536 sameAs 2943371536 @default.
• W2943371536 citedByCount "7" @default.
• W2943371536 countsByYear W29433715362019 @default.
• W2943371536 countsByYear W29433715362021 @default.
• W2943371536 countsByYear W29433715362022 @default.
• W2943371536 countsByYear W29433715362023 @default.
• W2943371536 crossrefType "journal-article" @default.
• W2943371536 hasAuthorship W2943371536A5000850537 @default.
• W2943371536 hasAuthorship W2943371536A5004263068 @default.
• W2943371536 hasAuthorship W2943371536A5016565734 @default.
• W2943371536 hasAuthorship W2943371536A5020247445 @default.
• W2943371536 hasAuthorship W2943371536A5023567302 @default.
• W2943371536 hasAuthorship W2943371536A5030951835 @default.
• W2943371536 hasAuthorship W2943371536A5033851269 @default.
• W2943371536 hasAuthorship W2943371536A5039854648 @default.
• W2943371536 hasAuthorship W2943371536A5048657899 @default.
• W2943371536 hasAuthorship W2943371536A5058390204 @default.
• W2943371536 hasAuthorship W2943371536A5087209063 @default.
• W2943371536 hasAuthorship W2943371536A5087367098 @default.
• W2943371536 hasBestOaLocation W29433715362 @default.
• W2943371536 hasConcept C100406419 @default.
• W2943371536 hasConcept C126322002 @default.
• W2943371536 hasConcept C138816342 @default.
• W2943371536 hasConcept C144133560 @default.
• W2943371536 hasConcept C159110408 @default.
• W2943371536 hasConcept C160735492 @default.
• W2943371536 hasConcept C162118730 @default.
• W2943371536 hasConcept C162324750 @default.
• W2943371536 hasConcept C3013748606 @default.
• W2943371536 hasConcept C50522688 @default.
• W2943371536 hasConcept C512399662 @default.
• W2943371536 hasConcept C524218345 @default.
• W2943371536 hasConcept C71924100 @default.
• W2943371536 hasConcept C72563966 @default.
• W2943371536 hasConceptScore W2943371536C100406419 @default.
• W2943371536 hasConceptScore W2943371536C126322002 @default.
• W2943371536 hasConceptScore W2943371536C138816342 @default.
• W2943371536 hasConceptScore W2943371536C144133560 @default.
• W2943371536 hasConceptScore W2943371536C159110408 @default.
• W2943371536 hasConceptScore W2943371536C160735492 @default.
• W2943371536 hasConceptScore W2943371536C162118730 @default.
• W2943371536 hasConceptScore W2943371536C162324750 @default.
• W2943371536 hasConceptScore W2943371536C3013748606 @default.
• W2943371536 hasConceptScore W2943371536C50522688 @default.
• W2943371536 hasConceptScore W2943371536C512399662 @default.
• W2943371536 hasConceptScore W2943371536C524218345 @default.
• W2943371536 hasConceptScore W2943371536C71924100 @default.
• W2943371536 hasConceptScore W2943371536C72563966 @default.
• W2943371536 hasIssue "6" @default.
• W2943371536 hasLocation W29433715361 @default.
• W2943371536 hasLocation W29433715362 @default.
• W2943371536 hasLocation W29433715363 @default.
• W2943371536 hasLocation W29433715364 @default.
• W2943371536 hasOpenAccess W2943371536 @default.
• W2943371536 hasPrimaryLocation W29433715361 @default.
• W2943371536 hasRelatedWork W1973460911 @default.
• W2943371536 hasRelatedWork W1990642809 @default.
• W2943371536 hasRelatedWork W2040946909 @default.
• W2943371536 hasRelatedWork W2064406802 @default.
• W2943371536 hasRelatedWork W2096903645 @default.
• W2943371536 hasRelatedWork W2315085516 @default.
• W2943371536 hasRelatedWork W2316407790 @default.
• W2943371536 hasRelatedWork W2603773853 @default.
• W2943371536 hasRelatedWork W2955255992 @default.
• W2943371536 hasRelatedWork W2964295425 @default.
• W2943371536 hasVolume "20" @default.
• W2943371536 isParatext "false" @default.
• W2943371536 isRetracted "false" @default.
• W2943371536 magId "2943371536" @default.
• W2943371536 workType "article" @default.